Chief Strategy and Corp Development Officer Director, Investor Relations · NEOGENOMICS INC (NEO)

William Bonello

FY2018 is the first fiscal year CompBrief holds for William Bonello as a named executive officer of NEOGENOMICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$820,145

Salary $337,692Stock awards $0

6th of 6 named executive officers at Neogenomics by FY2018 total.

6 named officers on file for NEOGENOMICS, FY2018

William Bonello’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • NEO’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how NEOGENOMICS’s whole pay program stands against its peers

  • NEOGENOMICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NEO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 22, 2019 (DEF 14A).

Free

Get William Bonello’s full pay file as a PDF — free

More than this page: up to 10 years of William’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

William Bonello compensation by year

NEOGENOMICS Summary Compensation Table · the one fiscal year held
In US dollars, as NEOGENOMICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$337,692
Bonus$0
Stock awards$0
Option awards$308,078
Non-equity incentive$174,375
Pension and deferred compensation$0
All other$0
Total$820,145

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NEOGENOMICS INC DEF 14A filed April 22, 2019, accession 0001193125-19-113593, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NEOGENOMICS INC filed document, accession 0001193125-19-113593. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2019.

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option66,000—$7.52
Option120,500—$8.03

Per the Outstanding Equity Awards at Fiscal Year-End table in NEOGENOMICS INC's FY2018 proxy; value at the fiscal year-end close, as the company printed it.

NEOGENOMICS’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Douglas VanOortChief Executive Officer & Chairman of the Board$3,347,219
Robert ShovlinPresident of Clinical Services$1,328,739
Sharon ViragChief Financial Officer$1,093,562
George CardozaPresident of Pharma Services$1,056,522
Lawrence WeissChief Scientific Officer$855,895
William Bonello · this pageChief Strategy and Corp Development Officer Director, Investor Relations$820,145

The full NEOGENOMICS compensation record

free company brief

This page is one person within NEOGENOMICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the NEOGENOMICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NEOGENOMICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

William Bonello's compensation dossier · One-time report. No refunds.